Analysts at Goldman Sachs on Tuesday restarted coverage on a number of regional bankers.

The firm resumed coverage on BBT with a “Buy” rating and $35 price target, suggesting a 17% upside to the stock’s Tuesday closing price of $29.96.

Goldman noted that BBT is better-positioned than other regional banking plays in the current environment. An analyst commented, “In addition to our expectations that BBT’s specialized lending platform and C&I share gains will drive outperformance vs. peers on organic growth, BBT is also best positioned to grow and add value via accretive acquistions.”

Meanwhile, Goldman Sachs restarted coverage on CMA with a “Sell” rating and $28 price target, suggesting an 8% downside to the stock’s Tuesday closing price of $30.39. The firm noted Comerica has several risk factors, including a premium valuation, possible NIM compression, and higher attrition levels.

Finally, Goldman also resumed coverage on ZION with a “Sell” rating and $18 price target, implying an 11% downside to the stock’s Tuesday closing price of $20.28. The firm commented, “In the near term, we see further compression in store for ZION’s above-average 3.9% NIM as new loans are originated at lower yields without the floors that have historically supported ZION’s NIM.”

The Bottom Line
Shares of BB&T (BBT) have a 2.67% dividend yield, based on last night’s closing stock price of $29.96. The stock has technical support in the $26 price area. If the shares can firm up, we see overhead resistance around the $30-$32 price levels. Shares of Comerica (CMA) have a 1.97% dividend yield, based on last night’s closing stock price of $30.39. The stock has technical support in the $26-$28 price area. If the shares can firm up, we see overhead resistance around the $32-$34 price levels. Shares of Zions Bancorp (ZION) have a .20% dividend yield, based on last night’s closing stock price of $20.28. The stock has technical support in the $16-$18 price area. If the shares can firm up, we see overhead resistance around the $22 price level.

None of the dividend stocks mentioned in this article are currently recommended by Dividend.com.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.